Veterinary Medicines

Miloxan Suspensie voor injectie

Not authorised
  • Clostridium chauvoei, Inactivated
  • Clostridium tetani, toxoid
  • Clostridium septicum, toxoid
  • Clostridium novyi, toxoid
  • Clostridium sordellii, toxoid
  • Clostridium perfringens, epsilon toxoid
  • Clostridium perfringens, beta toxoid
Download as PDF

Product identification

Medicine name:
Miloxan Suspensie voor injectie
Miloxan Suspension injectable
Miloxan Injektionslösung
Active substance:
  • Clostridium chauvoei, Inactivated
  • Clostridium tetani, toxoid
  • Clostridium septicum, toxoid
  • Clostridium novyi, toxoid
  • Clostridium sordellii, toxoid
  • Clostridium perfringens, epsilon toxoid
  • Clostridium perfringens, beta toxoid
Target species:
  • Sheep
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium chauvoei, Inactivated
    90.00
    percentage protection
    /
    2.00
    millilitre(s)
  • Clostridium tetani, toxoid
    2.50
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium septicum, toxoid
    2.50
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium novyi, toxoid
    3.50
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium sordellii, toxoid
    90.00
    percentage protection
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, epsilon toxoid
    5.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, beta toxoid
    10.00
    international unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Belgium
Package description:
  • Miloxan 250 ml Vial Suspension for injection
  • Miloxan 100 ml Vial Suspension for injection
  • Miloxan 50 ml Vial Suspension for injection
  • Miloxan 4 ml Vial Suspension for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V149037
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 21/03/2022
Download
French (PDF)
Published on: 21/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 21/03/2022
Download
French (PDF)
Published on: 21/03/2022
Download
German (PDF)
Published on: 21/03/2022
Download